Pricing AgreementBarclays PLC • March 6th, 2023 • Commercial banks, nec
Barclays PLC (the “Company”) proposes to issue £1,500,000,000 aggregate principal amount of 9.250% Fixed Rate Resetting Perpetual Subordinated Contingent Convertible Securities (the “Designated Securities”). The Designated Securities are convertible in accordance with their terms for stock of Barclays PLC as described in the Preliminary Prospectus Supplement (as defined in Schedule II hereto). Each of the Underwriters hereby undertakes to purchase at the subscription price set forth in Schedule II hereto (the “Subscription Price”), the amount of Designated Securities set forth opposite the name of such Underwriter in Schedule I hereto, such payment to be made at the Time of Delivery set forth in Schedule II hereto. The obligations of the Underwriters hereunder are several but not joint.
BARCLAYS PLC, as Issuer, THE BANK OF NEW YORK MELLON, LONDON BRANCH, as Trustee and Paying Agent and THE BANK OF NEW YORK MELLON SA/NV, LUXEMBOURG BRANCH, as Contingent Capital Security Registrar EIGHTH SUPPLEMENTAL INDENTURE Dated as of March 6, 2023...Eighth Supplemental Indenture • March 6th, 2023 • Barclays PLC • Commercial banks, nec • New York
EIGHTH SUPPLEMENTAL INDENTURE, dated as of March 6, 2023 (the “Eighth Supplemental Indenture”), among BARCLAYS PLC, a public limited company registered in England and Wales, as Issuer (hereinafter called the “Company”), having its registered office at 1 Churchill Place, London E14 5HP, United Kingdom, THE BANK OF NEW YORK MELLON, LONDON BRANCH, a New York banking corporation, as Trustee (herein called the “Trustee”) and Paying Agent, having its Corporate Trust Office at 160 Queen Victoria Street, London EC4V 4LA, United Kingdom and THE BANK OF NEW YORK MELLON SA/NV, LUXEMBOURG BRANCH, as Contingent Capital Security Registrar, having an office at 2-4 Rue Eugene Ruppert, Vertigo Building – Polaris, Luxembourg, L-2453, Luxembourg (herein called the “Contingent Capital Security Registrar”), to the CONTINGENT CAPITAL SECURITIES INDENTURE, dated as of August 14, 2018 among the Company, the Trustee and the Contingent Capital Security Registrar, as heretofore amended and supplemented (the “Bas
